Citation

82 FR 36808

Canonical document for this Federal Register citation.

Prospective Grant of Exclusive Patent License: The Development of a Bispecific, Biparatopic Antibody-Drug Conjugate to GPC3 for the Treatment of Human Liver Cancers Monday, August 7, 2017 82 FR 36808